Abstract | OBJECTIVE: DESIGN: Clinical trial. ANIMALS: 39 healthy alpacas on 1 farm and 86 healthy alpacas on a second farm. PROCEDURES: RESULTS: For alpacas on the first farm, geometric mean virus neutralizing antibody titer peaked 2 weeks after the third vaccine dose was given (ie, day 70). At this time, 29 of 38 (76%) animals were seropositive for antibodies against EEE virus, and percentage of animals <or= 2 years old that were seropositive (16/17) was significantly higher than percentage of animals > 6 years old that were seropositive (1/5). For alpacas on the second farm, 76 (88%) were seropositive on day 70, and percentage of animals <or= 2 years old that were seropositive (24/24) was significantly higher than percentage of animals > 6 years old that were seropositive (27/33). For both farms, geometric mean titer on day 70 was significantly higher in animals < 2 years old than in animals > 6 years old. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that inoculation of alpacas with 3 doses of a bivalent, killed-virus equine encephalitis vaccine induced a humoral antibody response against EEE virus.
|
Authors | Daniela Bedenice, Amy Bright, Douglas D Pedersen, Jack Dibb |
Journal | Journal of the American Veterinary Medical Association
(J Am Vet Med Assoc)
Vol. 234
Issue 4
Pg. 530-4
(Feb 15 2009)
ISSN: 0003-1488 [Print] United States |
PMID | 19222365
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Vaccines, Inactivated
- Viral Vaccines
|
Topics |
- Animals
- Antibodies, Viral
(biosynthesis, blood)
- Antibody Formation
- Camelids, New World
(blood, immunology, virology)
- Dose-Response Relationship, Immunologic
- Encephalitis Virus, Eastern Equine
(immunology)
- Encephalomyelitis, Eastern Equine
(blood, immunology, prevention & control, veterinary)
- Female
- Injections, Intramuscular
(veterinary)
- Male
- Vaccination
(veterinary)
- Vaccines, Inactivated
- Viral Vaccines
(administration & dosage, immunology)
|